Bill

Bill > AB634


CA AB634

CA AB634
Tianeptine.


summary

Introduced
02/13/2025
In Committee
06/24/2026
Crossed Over
01/29/2026
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

An act to add Chapter 16.7 (commencing with Section 109024) to Part 3 of Division 104 of the Health and Safety Code, relating to public health.

AI Summary

This bill prohibits any entity, defined as a sole proprietorship, partnership, limited liability company, corporation, or other business entity, from manufacturing, distributing, or selling in California any product that contains tianeptine or is marketed as containing tianeptine. Violations of this prohibition can result in civil penalties of up to $2,500 for a first offense and up to $5,000 for subsequent offenses, with legal actions brought by the Attorney General, a city attorney, or a county counsel. Additionally, a successful plaintiff in such an action will be awarded reasonable attorney's fees and costs, and these remedies are in addition to any other legal options available.

Committee Categories

Budget and Finance, Health and Social Services, Justice

Sponsors (7)

Last Action

Senate Appropriations Hearing (10:00:00 8/3/2026 1021 O Street, Room 2200) (on 08/03/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
  • ‐ Regulation of Drug Industry and Pharmacies

bill text


bill summary

Loading...

bill summary

Loading...
Loading...